The store will not work correctly when cookies are disabled.
N-(4-((2-Aminoethyl)amino)-2-chlorophenyl)-5-chloro-2-hydroxybenzamide
ID: ALA4782099
PubChem CID: 162665246
Max Phase: Preclinical
Molecular Formula: C15H15Cl2N3O2
Molecular Weight: 340.21
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NCCNc1ccc(NC(=O)c2cc(Cl)ccc2O)c(Cl)c1
Standard InChI: InChI=1S/C15H15Cl2N3O2/c16-9-1-4-14(21)11(7-9)15(22)20-13-3-2-10(8-12(13)17)19-6-5-18/h1-4,7-8,19,21H,5-6,18H2,(H,20,22)
Standard InChI Key: PHUCPEVSXBLDTG-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
14.4620 -7.8094 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7462 -7.3969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7462 -6.5719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0344 -6.1594 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3187 -6.5719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6028 -6.1594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8911 -6.5719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8911 -7.3969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6028 -7.8094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3187 -7.3969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4593 -7.3969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7477 -7.8094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0318 -7.3969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3160 -7.8094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3160 -8.6344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0318 -9.0469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7477 -8.6344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4593 -6.5719 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1752 -7.8094 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0318 -6.5719 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0318 -9.8719 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
10.1752 -6.1594 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
5 10 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
12 17 2 0
11 18 2 0
11 19 1 0
13 20 1 0
16 21 1 0
8 19 1 0
7 22 1 0
4 5 1 0
3 4 1 0
1 2 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 340.21 | Molecular Weight (Monoisotopic): 339.0541 | AlogP: 3.32 | #Rotatable Bonds: 5 |
Polar Surface Area: 87.38 | Molecular Species: BASE | HBA: 4 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.39 | CX Basic pKa: 9.62 | CX LogP: 1.72 | CX LogD: 1.52 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.67 | Np Likeness Score: -1.56 |
References
1. Xu J,Berastegui-Cabrera J,Ye N,Carretero-Ledesma M,Pachón-Díaz J,Chen H,Pachón-Ibáñez ME,Sánchez-Céspedes J,Zhou J. (2020) Discovery of Novel Substituted N-(4-Amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide Analogues as Potent Human Adenovirus Inhibitors., 63 (21): [PMID:33112138] [10.1021/acs.jmedchem.0c01226] |